The approval of this drug represents a significant breakthrough in reproductive health care for American women. It promises to give women, especially those who live far from an abortion provider, better access to a safe, private and early option for ending a pregnancy. The great promise of mifepristone is threatened, however, by anti-choice extremists who have introduced legislation that would impose severe and unwarranted restrictions on the use of this drug. Any new restrictions placed on mifepristone would severely limit access to this important drug and place it out of reach for many American women. Urge your Members of Congress to reject this attempt to inject anti-choice politics into medical decision making.
Mifepristone represents an important new reproductive health care option for American women.
Yet the same anti-choice forces who have spent the past six years chipping away at a woman's right to choose one step at a time should not be allowed to rob women of this significant medical advancement. Mifepristone promises to give women, especially those who live far from an abortion provider, better access to a safe, private, and early option for ending a pregnancy. Additionally, researchers have identified many potential uses for mifepristone beyond pregnancy termination, including the treatment of breast cancer, endometriosis, glaucoma, meningioma, ovarian cancer, prostate cancer and other conditions. Further restriction is not medically necessary. In the last decade, more than half a million women in Europe have safely used mifepristone, as have thousands of American women in clinical trials.